OR WAIT null SECS
September 03, 2020
The new line will add capacity to Catalent’s pipeline of clinical programs and commercial launches at the site.
September 01, 2020
The facility offers office, production, sampling, and warehouse space and delivers products to all major global markets.
Oxford Biomedica will reserve capacity for AstraZeneca in three of its manufacturing suites in its new commercial manufacturing center, Oxbox, for 18 months.
August 31, 2020
The new facility, located in Lenexa, KS, will rapidly expand production of viral transport media.
How real estate can accelerate productivity as life sciences companies prioritize COVID-19 therapeutics, vaccines, and new diagnostics R&D amidst new guidelines.
August 26, 2020
Medical management services provider, Europital, has announced the opening of a new site in Oxford, United Kingdom, in response to demand from small and medium innovators within the biotech industry.
August 13, 2020
The company has made several moves in recent weeks to expand manufacturing capacity and cell line services.
August 07, 2020
The European Medicines Agency recently approved two European Novartis sites in France and Switzerland for the commercial manufacturing of chimeric antigen receptor T-cell cell therapies.
August 06, 2020
The expanded facility will feature two new 40-L and 300-L manufacturing vessels, a capsule filling line, and six drying tunnels that will add more than 10 million doses per annum to the site.
The new facility will give the company’s Australian customers access to tablet formulation and coating services in order to shorten supply chains and increase the region’s pharmaceutical sector capacity.